ArticleHepatocellular Regeneration and Necrosis Markers in Chronic HCV Patients under Sofosbuvir-Based Regimen
ArticleHepatocellular Regeneration and Necrosis Markers in Chronic HCV Patients under Sofosbuvir-Based Regimen
ArticleSafety and Efficacy of Ombitasvir, Paritaprevirand Ritonavir Combination with Ribavirin for Treatment of Chronic Hepatitis C Virus in Advanced Kidney Diseases Patients in Upper E
ArticleSafety and Efficacy of Ombitasvir, Paritaprevirand Ritonavir Combination with Ribavirin for Treatment of Chronic Hepatitis C Virus in Advanced Kidney Diseases Patients in Upper E
ArticleMean Platelet Volume and Mean Platelet Volume/Platelet Count Ratio as Diagnostic Markers for Hepatocellular Carcinoma in Chronic Hepatitis C Patients
ArticleMean Platelet Volume and Mean Platelet Volume/Platelet Count Ratio as Diagnostic Markers for Hepatocellular Carcinoma in Chronic Hepatitis C Patients
ArticleCorrelation between Liver function tests, lipid profile and fibroscan in non-alcoholic fatty liver disease
ArticleCorrelation between Liver function tests, lipid profile and fibroscan in non-alcoholic fatty liver disease
ArticleEffect of viral load on hepatic fibrosis in patients with chronic hepatitis B patients: assessed by fibroscan
ArticleEffect of viral load on hepatic fibrosis in patients with chronic hepatitis B patients: assessed by fibroscan
ArticleValue of Helicobacter pylori Eradication on Platelet Count in chronic Hepatitis C Virus-Infected Patients with thrombocytopenia
ArticleValue of Helicobacter pylori Eradication on Platelet Count in chronic Hepatitis C Virus-Infected Patients with thrombocytopenia
ArticleLiver Fibrosis Assessment in Cases of Chronic Hepatitis C after Direct Acting Antivirals Therapy using Aspartate Aminotransferase to Platelet Ratio Index and Transient Elastograph
ArticleLiver Fibrosis Assessment in Cases of Chronic Hepatitis C after Direct Acting Antivirals Therapy using Aspartate Aminotransferase to Platelet Ratio Index and Transient Elastograph
ArticleEFFECT OF HCV DIRECT ANTIVIRAL AGENTS ON PORTAL CIRCULATION HEMODYNAMICS IN CIRRHOTIC PATIENTS
ArticleEFFECT OF HCV DIRECT ANTIVIRAL AGENTS ON PORTAL CIRCULATION HEMODYNAMICS IN CIRRHOTIC PATIENTS
ArticleRole of Eltrompobag in treatment of thrombocytopenia associated with chronic Hepatitis C Virus
ArticleRole of Eltrompobag in treatment of thrombocytopenia associated with chronic Hepatitis C Virus